West Family Investments Inc. Makes New $828,000 Investment in Boston Scientific Corporation $BSX

West Family Investments Inc. purchased a new stake in shares of Boston Scientific Corporation (NYSE:BSX – Free Report) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 18,958 shares of the medical equipment provider’s stock, valued at approximately $828,000.

Other institutional investors have also modified their holdings of the company. BlackRock Inc. bought a new stake in Boston Scientific in the 2nd quarter valued at about $5,534,781,000. Primecap Management Co. CA acquired a new position in Boston Scientific during the 2nd quarter valued at about $2,156,233,000. Janus Henderson Group PLC boosted its stake in Boston Scientific by 31.0% during the 1st quarter. Janus Henderson Group PLC now owns 16,497,366 shares of the medical equipment provider’s stock valued at $1,035,202,000 after purchasing an additional 3,907,981 shares during the period. Amundi grew its position in Boston Scientific by 13.8% in the 1st quarter. Amundi now owns 14,122,913 shares of the medical equipment provider’s stock worth $886,213,000 after purchasing an additional 1,707,754 shares during the last quarter. Finally, Arrowstreet Capital Limited Partnership grew its position in Boston Scientific by 25.9% in the 1st quarter. Arrowstreet Capital Limited Partnership now owns 13,891,668 shares of the medical equipment provider’s stock worth $871,702,000 after purchasing an additional 2,856,040 shares during the last quarter. Institutional investors own 89.07% of the company’s stock.

Boston Scientific Stock Performance

Shares of BSX opened at $44.33 on Monday. The firm has a 50-day moving average price of $44.00 and a 200 day moving average price of $54.50. The firm has a market capitalization of $64.25 billion, a PE ratio of 18.78, a P/E/G ratio of 1.31 and a beta of 0.60. The company has a quick ratio of 0.81, a current ratio of 1.36 and a debt-to-equity ratio of 0.42. Boston Scientific Corporation has a 52-week low of $39.57 and a 52-week high of $104.61.

Boston Scientific (NYSE:BSX – Get Free Report) last released its quarterly earnings results on Wednesday, October 28th. The medical equipment provider reported $0.73 EPS for the quarter, hitting analysts’ consensus estimates of $0.73. Boston Scientific had a net margin of 16.62% and a return on equity of 18.61%. The company had revenue of $5.14 billion for the quarter, compared to the consensus estimate of $5.09 billion. During the same period in the previous year, the firm earned $0.75 EPS. Boston Scientific’s revenue was up 1.4% on a year-over-year basis. On average, sell-side analysts anticipate that Boston Scientific Corporation will post 3.17 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

BSX has been the topic of several analyst reports. Leerink Partners dropped their price target on shares of Boston Scientific from $55.00 to $50.00 and set an “outperform” rating on the stock in a research note on Thursday, October 29th. Citigroup reduced their price objective on Boston Scientific from $48.00 to $44.00 and set a “neutral” rating for the company in a research report on Thursday, October 29th. Mizuho set a $50.00 price objective on Boston Scientific in a report on Thursday, October 29th. UBS Group lowered their target price on Boston Scientific from $67.00 to $57.00 and set a “buy” rating on the stock in a research report on Thursday, October 29th. Finally, Stifel Nicolaus cut their target price on Boston Scientific from $60.00 to $55.00 and set a “buy” rating on the stock in a research note on Monday, October 26th. One analyst has rated the stock with a Strong Buy rating, twenty have given a Buy rating, eight have issued a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $61.43.

Check Out Our Latest Report on Boston Scientific

About Boston Scientific

(Free Report)

Boston Scientific is a medical technology company that develops, manufactures and markets devices used in minimally invasive procedures across a range of medical specialties. Founded in 1979, the company is headquartered in Marlborough, Massachusetts. Its products support areas including cardiovascular care, endoscopy, urology and neuromodulation. They include catheter-based devices and therapies for conditions affecting the heart and blood vessels, as well as devices used in diagnostic and therapeutic procedures involving the digestive and urinary systems.

Recommended Stories

Institutional Ownership by Quarter for Boston Scientific (NYSE:BSX)

Receive News & Ratings for Boston Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Boston Scientific and related companies with MarketBeat.com's FREE daily email newsletter.